Anthropic said it acquired Mithril Medicine, a one-person startup developing treatments for two rare forms of muscular dystrophy, a sign of the AI developer’s growing ambitions in drug discovery. The company also said it is working with Bristol Myers Squibb, BigHat Biosciences and four other partners to use Claude for tasks ranging from antibody design to clinical trial planning. Mithril
The Information ·